POLYRIZON LTD
PLRZNASDAQπ #4844 by market capUS Equity
$9.00β² $0.04 (+0.50%)
Market closed Β· at closeTrack PLRZ
Get earnings, price moves & breaking news on Telegram
24hβ² 0.5%
7dβ² 0.5%
14dβΌ 12.1%
30dβΌ 18.4%
ytdβ² 11.0%
1yβ² 44.2%
π¦Market Cap
$10M
Small Cap
πRevenue Growth (YoY)
0.0%
Slowing
πGross Margin
0.0%
Thin
π΅FCF Margin
0.0%
Thin
βοΈP/S Ratio
0.0x
Cheap
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $9.00 β $9.00
- 52-Week Range
- $2.88 β $18.20
- Volume (shares)
- 156
- Avg Volume (shares)
- β
- Shares Outstanding
- 1.1M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- -1.9
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-3.02
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +11801.6%
POLYRIZON LTD
PLRZFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$6Mβ² +380.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$5Mβ² +295.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
1.6Mβ² +11801.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$1MβΌ β$1M YoY
About POLYRIZON LTD
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
πQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst data unavailable.
Latest News & Updates
News unavailable.